Sionna Therapeutics

Sionna Therapeutics

生物技术

Boston,MA 4,317 位关注者

Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis.

关于我们

We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.

网站
https://www.sionnatx.com/
所属行业
生物技术
规模
11-50 人
总部
Boston,MA
类型
私人持股
创立
2019
领域
life sciences、biotechnology、pharmaceuticals、cystic fibrosis、protein function、genetics、genetic mutation、genetic disease、clinical research、clinical study、research、small molecule、molecular engineering、chemistry、patient advocacy、drug development、clinical development、lung、orphan disease和rare disease

地点

Sionna Therapeutics员工

动态

相似主页

查看职位

融资